3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18F-FDG PET/CT Case Report.
Pharmaceuticals March 31, 2024 Maria Pepe, Marco Di Nicola, Fabrizio Cocciolillo et al. 6 citations
New Psychoactive Substances (NPS) are modifying the drug scenario worldwide and have become a public health concern because of their toxicological profiles and their harmful physical/psychological effects. 3-Methoxy-Phencyclidine (3-MeO-PCP), a non-competitive antagonist of glutamate N-methyl-D-aspartate (NMDA) receptors, belongs to the phencyclidine-like subfamily of arylcyclohexylamines and...
DOI: 10.3390/ph17040452 (opens in new tab)
Full text (opens in new tab)
3-meo-pcp
Nps
Cognitive functioning
Neuroimaging
+1